Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice
Authors
Keywords
-
Journal
TUBERCULOSIS
Volume 137, Issue -, Pages 102268
Publisher
Elsevier BV
Online
2022-10-04
DOI
10.1016/j.tube.2022.102268
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Penicillin Binding Proteins and β-Lactamases of Mycobacterium tuberculosis: Reexamination of the Historical Paradigm
- (2022) Gaurav Kumar et al. mSphere
- T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren
- (2022) Binayak Rimal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data
- (2021) Saskia E Mudde et al. JOURNAL OF INFECTIOUS DISEASES
- Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen
- (2021) Laura Victoria et al. Frontiers in Cellular and Infection Microbiology
- Treatment of Mycobacterium abscessus Pulmonary Disease
- (2021) David E. Griffith et al. CHEST
- “One-Two Punch”: Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes
- (2021) David C Nguyen et al. CLINICAL INFECTIOUS DISEASES
- Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
- (2021) Matt D. Johansen et al. Disease Models & Mechanisms
- Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection
- (2021) Rebekah M. Dedrick et al. NATURE MEDICINE
- Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
- (2021) Danielle A. Nicklas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disseminated Mycobacterium abscessus subspecies massiliense infection and subsequent prosthetic joint infection in a hemodialysis patient: A case report
- (2021) Yu Tsuruyama et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria
- (2021) Herman O.I. Pfaeffle et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
- (2021) Jaryd R. Sullivan et al. PLoS Pathogens
- Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
- (2021) Bui Thi Bich Hanh et al. Frontiers in Pharmacology
- Synergistic interactions of indole-2-carboxamides and β-lactam antibiotics against Mycobacterium abscessus
- (2020) Clément Raynaud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease
- (2020) Thomas Dick Frontiers in Microbiology
- Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice
- (2020) Vincent Le Moigne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Minimal Inhibitory Concentration of Clofazimine among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome
- (2020) Nakwon Kwak et al. CHEST
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria (NTM)
- (2020) Barbara A. Brown-Elliott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of a penem antibiotic against Mycobacteroides abscessus
- (2020) Hunter R. Batchelder et al. Communications Biology
- Indole-2-carboxamides are Active Against an Acute Mycobacterium abscessus Infected Mouse Model
- (2019) Amit N. Pandya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia
- (2019) Pranita D. Tamma et al. JAMA Internal Medicine
- Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro
- (2019) R. Pandey et al. mBio
- Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
- (2019) Nakwon Kwak et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis
- (2019) Vikram Saini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex
- (2019) Aristine Cheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and Intracellular Activity of Imipenem Combined with Tedizolid, Rifabutin, and Avibactam against Mycobacterium abscessus
- (2019) Eva Le Run et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activities of omadacycline against rapidly growing mycobacteria
- (2019) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
- (2019) Hannelore I Bax et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mouse Models as Resources for Studying Infectious Diseases
- (2019) Sanjay Sarkar et al. CLINICAL THERAPEUTICS
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach
- (2019) Yang Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China
- (2018) Jingjing Luo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis
- (2018) Matthew Schwartz et al. Microbial Drug Resistance
- Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera
- (2018) Radhey S. Gupta et al. Frontiers in Microbiology
- Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study
- (2018) Rein Willekens et al. CLINICAL INFECTIOUS DISEASES
- Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer
- (2018) Sarah C J Jorgensen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus
- (2017) Amit Kaushik et al. Future Microbiology
- The “Choosing Wisely” initiative in infectious diseases
- (2017) Clara Lehmann et al. INFECTION
- Minimum inhibitory concentration distributions for Mycobacterium avium complex—towards evidence-based susceptibility breakpoints
- (2017) Thomas Schön et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
- (2017) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- (2017) Charles S Haworth et al. THORAX
- Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
- (2017) Sarah A McGuffin et al. Open Forum Infectious Diseases
- Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents
- (2016) Miao Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Mouse Models for Drug Discovery. Can New Tools and Technology Improve Translational Power?
- (2016) Aamir Zuberi et al. ILAR JOURNAL
- Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov.
- (2016) Enrico Tortoli et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Clofazimine has delayed antimicrobial activity againstMycobacterium tuberculosisbothin vitroandin vivo
- (2016) Nicole C. Ammerman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus
- (2016) Christian Dupont et al. MOLECULAR MICROBIOLOGY
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis
- (2015) Rosemary V. Swanson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
- (2015) S. M. Irwin et al. Disease Models & Mechanisms
- Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
- (2015) J.-P. Lanoix et al. Disease Models & Mechanisms
- Disseminated Mycobacterium abscessus Infection Following Septic Arthritis
- (2015) Shoichi Fukui et al. MEDICINE
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
- (2015) R Andres Floto et al. THORAX
- Nontuberculous Mycobacteria among Patients with Cystic Fibrosis in the United States. Screening Practices and Environmental Risk
- (2014) Jennifer Adjemian et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex
- (2014) S. Singh et al. CLINICAL MICROBIOLOGY AND INFECTION
- -Lactamase inhibition by avibactam in Mycobacterium abscessus
- (2014) V. Dubee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus
- (2014) F. P. Maurer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systematic review of clofazimine for the treatment of drug-resistant tuberculosis [Review article]
- (2013) M. Gopal et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
- (2013) Isabelle Lerat et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
- (2012) Emily R. Driver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
- (2012) Ian M. Rosenthal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSynergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
- (2012) Jakko van Ingen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
- (2012) B. A. Brown-Elliott et al. CLINICAL MICROBIOLOGY REVIEWS
- New drugs for the treatment of tuberculosis: hope and reality [State of the Art Series. New tools. Number 2 in the series]
- (2012) J. H. Grosset et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Mycobacterium abscessus: a new antibiotic nightmare
- (2012) R. Nessar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
- (2011) Julie Jarand et al. CLINICAL INFECTIOUS DISEASES
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
- (2010) D. Rebecca Prevots et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Significance of Differentiation ofMycobacterium massiliensefromMycobacterium abscessus
- (2010) Won-Jung Koh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Case of Skin and Soft Tissue Infection Caused byMycobacterium abscessus
- (2010) Yong Hyun Kwon et al. Annals of Dermatology
- Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs againstMycobacterium tuberculosis
- (2010) Mary A. De Groote et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
- (2010) Gwan-Han Shen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Requirements for a lead compound to become a clinical candidate
- (2008) Franz F Hefti BMC NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now